Black Rose Industries Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/sqh4zjx30hhjenr6vjvphpue.pdf

Key Takeaways


Revenue Drivers & Product Performance

Ambarish Daga: "as a general, policy or a general framework, we would be entering into manufacturing arrangement only when there are better margins compared to the distribution business. Otherwise, it would not make any sense for manufacturing."

Margin Structure & Profitability Path

Ambarish Daga: "as the scale of operation will grow, as the size of the company grows, as the segment wise distribution pattern changes between the distribution business and the manufacturing business, you will see much healthier net profit margins overall for the company."

Strategic Projects & Capex

Ambarish Daga: "in all such collaborations, basically there are secrecy agreements which bars us from mentioning too much details."

External Environment & Opportunities

Ambarish Daga: "the duty will definitely help and we see that as a big opportunity for not just our manufactured business, but also for our distribution business... But we'll have to see how it finally plays out. Currently it's just been announced so it is difficult to gauge the actual impact."

Guidance & Commitments

CommitmentSpecificsTimeline
Polyacrylamide solids technology completionTechnology development finishedEnd of current financial year
Polyacrylamide solids commercializationCommercial production beginsTowards end of upcoming financial year
New R&D center completionFacility operationalEnd of this quarter
Brownfield specialty chemical EC applicationFinal application submittedWithin this week (from call date)
Volume and revenue growthSubstantial growth in both, focus on exportsCurrent financial year
Logistics easing to support volumesFreight rates declining, issues easing outNext upcoming quarters
Japanese JV disclosureMore information provided publiclyWhen EC application is approved

Key Metrics

MetricQ3 FY25
Revenue from operations~48% YoY growth, minor dip QoQ
EBITDA margin~10%, improved from ~8% in the corresponding quarter of the previous year
PAT marginHealthy growth YoY
Return on capital employed19%
Exports share of revenue30%, up from 18% in Q2 FY25
Distribution share of revenue~2/3
Distribution business exportsMore than double YoY
Top 5 distribution products share of distribution top line93%
Top 5 distribution products share of distribution profits85%
Acrylonitrile price~$1,200 at quarter start, rose gradually; up another $100 in the current month
New binder product sales growth>50% over average monthly sales of Q2 FY25
Unallocated revenue₹86 lakhs, with an operating loss of ~₹1 crore
Long-term debtNil, company remains long-term debt free
Debt-equity ratioNegligible